J&J Agrees To Settle A Risperdal Lawsuit Before Trial
J&J Agrees To Settle A Risperdal Lawsuit Before Trial
Introduction
Johnson & Johnson agreed to settle a Mississippi plaintiff's case involving Risperdal side-effects, days before going to the trial. The plaintiff was a young boy when he was diagnosed with bipolar disorder in 2004 for which he took Risperdal medication. The lawsuit filed by his parents stated that he gained weight and developed breasts soon after starting the course.
A law firm also stated that the boy, “suffered considerable ridicule in school, causing a great deal of childhood trauma and shame.” Risperdal was approved to be used as a bipolar disorder drug for adolescents in 2007. However, J&J still faces 13,500 cases involving allegations by individuals that the company purposely concealed the gynecomastia risks from patients and doctors.
Two coordinated actions have been filed for Risperdal cases: one in Los Angeles Superior Court (Risperdal and Invega Product Liability Cases, JCCP 4775) and the other in Philadelphia (In Re: Risperdal Litigation, March 2010 Term, Case No. 100300296).
Comments
Latest News
Attorneys Seek Reconsideration of Talc MDL Daubert Ruling
Categories: General
Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…
Philips resolves DreamStation suits for $1.1B
Categories: Settlements
Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…
FDA OKs Generic OTC Naloxone Spray Approved by FDA
Categories: FDA Related
The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.
…